Octave Bioscience, a commercial-stage precision care company pioneering a new standard for managing multiple sclerosis (MS) and other neurodegenerative diseases such as Parkinson's disease, today ...
Octave Bioscience, a commercial-stage precision care company pioneering a new standard for managing multiple sclerosis (MS) ...
Cladribine is linked to lower risk for disability progression in patients with relapsing-remitting multiple sclerosis vs ...
What are called autoimmune diseases can affect just about every part of the body — even the brain — and tens of millions of ...
An insurance company repeatedly denied a Wisconsin woman coverage for a medication her doctor prescribed to treat her ...
Explore how the Veteran Affairs (VA) MS Centers of Excellence enhance veteran care through a hub-and-spoke model, telehealth, ...
CAR T-cell therapy, which transforms patients’ own immune cells into cancer-fighting warriors, has been extremely effective ...
What are called autoimmune diseases can affect just about every part of the body — and tens of millions of people. While most ...
The VISTA trial was a randomized, double-blind, placebo-controlled, multi-center study designed to evaluate PIPE-307’s safety and efficacy in RRMS patients. The company continues to analyze data from ...
Ciba Health collaborates with Canadian health benefits administrator Quikcard, and Octave Bioscience signs a partnership ...
NEWTON, Mass., November 13, 2025--(BUSINESS WIRE)--Inflammasome Therapeutics (https://www.inflam.com), a clinical-stage biotech company developing a new class of drugs, Kamuvudines, for ophthalmic and ...
Many people permanently on ventilators prefer to live at home as long as they can. But care there can be perilous and pricey.